DK1861711T3 - Anvendelse af MGC4504 - Google Patents

Anvendelse af MGC4504

Info

Publication number
DK1861711T3
DK1861711T3 DK06723224.9T DK06723224T DK1861711T3 DK 1861711 T3 DK1861711 T3 DK 1861711T3 DK 06723224 T DK06723224 T DK 06723224T DK 1861711 T3 DK1861711 T3 DK 1861711T3
Authority
DK
Denmark
Prior art keywords
mgc4504
fragment
application
protein
derivative
Prior art date
Application number
DK06723224.9T
Other languages
English (en)
Inventor
Marc Dietrich Voss
Georg Tschank
Marcus Hermann Korn
Original Assignee
Sanofi Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Sa filed Critical Sanofi Sa
Application granted granted Critical
Publication of DK1861711T3 publication Critical patent/DK1861711T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/566—Immunoassay; Biospecific binding assay; Materials therefor using specific carrier or receptor proteins as ligand binding reagents where possible specific carrier or receptor proteins are classified with their target compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K4/00—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof
    • C07K4/12—Peptides having up to 20 amino acids in an undefined or only partially defined sequence; Derivatives thereof from animals; from humans

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
DK06723224.9T 2005-03-11 2006-03-06 Anvendelse af MGC4504 DK1861711T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05005383 2005-03-11
PCT/EP2006/002020 WO2006094735A1 (en) 2005-03-11 2006-03-06 Use of mgc4504

Publications (1)

Publication Number Publication Date
DK1861711T3 true DK1861711T3 (da) 2012-04-16

Family

ID=34934214

Family Applications (1)

Application Number Title Priority Date Filing Date
DK06723224.9T DK1861711T3 (da) 2005-03-11 2006-03-06 Anvendelse af MGC4504

Country Status (13)

Country Link
US (1) US20080249011A1 (da)
EP (1) EP1861711B1 (da)
JP (1) JP4960951B2 (da)
KR (1) KR101338885B1 (da)
CN (1) CN101147066A (da)
AT (1) ATE541212T1 (da)
AU (1) AU2006222204B2 (da)
BR (1) BRPI0609209A2 (da)
CA (1) CA2600209A1 (da)
DK (1) DK1861711T3 (da)
IL (1) IL185806A (da)
MX (1) MX2007010835A (da)
WO (1) WO2006094735A1 (da)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2397559A1 (en) 2010-06-17 2011-12-21 Max-Delbrück-Centrum Für Molekulare Medizin Stage-specific biomarkers for the diagnosis of acute kidney injury

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8308235D0 (en) * 1983-03-25 1983-05-05 Celltech Ltd Polypeptides
US4816567A (en) 1983-04-08 1989-03-28 Genentech, Inc. Recombinant immunoglobin preparations
WO1988001649A1 (en) 1986-09-02 1988-03-10 Genex Corporation Single polypeptide chain binding molecules
ES2052027T5 (es) 1988-11-11 2005-04-16 Medical Research Council Clonacion de secuencias de dominio variable de inmunoglobulina.
US6300129B1 (en) 1990-08-29 2001-10-09 Genpharm International Transgenic non-human animals for producing heterologous antibodies
ATE181571T1 (de) 1991-09-23 1999-07-15 Medical Res Council Methoden zur herstellung humanisierter antikörper
FR2739031B1 (fr) 1995-09-27 1997-11-21 Lhd Lab Hygiene Dietetique Systeme matriciel transdermique d'administration d'un oestrogene et/ou d'un progestatif a base de copolymere styrene-isoprene-styrene, procede de preparation et utilisation en therapeutique
US5736154A (en) 1996-03-11 1998-04-07 Fuisz Technologies Ltd. Transdermal delivery system
SK130298A3 (en) 1996-03-25 1999-03-12 Lohmann Therapie Syst Lts Transdermal therapeutic system with small application-area thickness and great flexibility, and production process
AUPO379596A0 (en) 1996-11-22 1996-12-19 Soltec Research Pty Ltd Percutaneous delivery system
US6391312B1 (en) * 1997-01-23 2002-05-21 Sumitomo Pharmaceuticals Co., Limited Remedies for diabetes
WO2000026245A2 (en) 1998-11-04 2000-05-11 Incyte Pharmaceuticals, Inc. Human membrane transport proteins
US6177248B1 (en) * 1999-02-24 2001-01-23 Affymetrix, Inc. Downstream genes of tumor suppressor WT1
US20040259777A1 (en) 2001-06-07 2004-12-23 Kenneth Thirstrup Method of treating metabolic disorders using neuronatin polypeptides
WO2003063889A1 (en) * 2002-01-31 2003-08-07 Joslin Diabetes Center, Inc. METHODS OF MODULATING β CELL FUNCTION
AU2003304707A1 (en) * 2002-12-20 2005-08-16 Nuvelo, Inc. Legal Department Novel nucleic acids and polypeptides
EP1602666A4 (en) * 2003-03-10 2006-05-24 Takeda Chemical Industries Ltd NEW PROTEIN AND ITS DNA

Also Published As

Publication number Publication date
IL185806A0 (en) 2008-01-06
IL185806A (en) 2013-07-31
KR20080005185A (ko) 2008-01-10
AU2006222204A1 (en) 2006-09-14
EP1861711B1 (en) 2012-01-11
CN101147066A (zh) 2008-03-19
WO2006094735A1 (en) 2006-09-14
CA2600209A1 (en) 2006-09-14
JP2008532503A (ja) 2008-08-21
KR101338885B1 (ko) 2013-12-12
AU2006222204B2 (en) 2012-09-27
EP1861711A1 (en) 2007-12-05
BRPI0609209A2 (pt) 2010-03-02
JP4960951B2 (ja) 2012-06-27
US20080249011A1 (en) 2008-10-09
MX2007010835A (es) 2007-11-09
ATE541212T1 (de) 2012-01-15

Similar Documents

Publication Publication Date Title
DK1907037T3 (da) Medikamentdispenser.
NL1030571A1 (nl) Geurafgiftesysteem.
ITTV20050084A1 (it) Calzatura con suola traspirante.
NL1031912A1 (nl) Gestapeld ontlaatsysteem.
NL1032915A1 (nl) Katheterpunt.
NL1032108A1 (nl) Geurafgiftesysteem.
NL1033024A1 (nl) Interferometer met geringe afwijking ('walk-off').
DK1861711T3 (da) Anvendelse af MGC4504
ITTV20050063A1 (it) Struttura di calzatura.
ITRC20050012A1 (it) "palmira la bottiglia che attira".
ES1061015Y (es) Calzado ortopedico.
ITPR20050063A1 (it) Apparato di sterilizzazione.
ES1060080Y (es) Calzado adaptable.
UA12361S (uk) Комплект етикеток для настоянки «полісянка. медовий персик на коньяку»
ES1058582Y (es) Calzado perfeccionado.
ES1061263Y (es) Herradura.
NO20053941D0 (no) Oversko/kalosjer.
ITTV20050103A1 (it) Struttura di stivale, particolarmente per la pratica del motocross.
NO20052896D0 (no) Vegg-laser-reklame.
NL1032780A1 (nl) Verbeterd hoefijzer.
ITSS20050005U1 (it) Carolina multimediale.
ES1058496Y (es) Calzador perfeccionado.
BRPI0400804B1 (pt) sistema de encaixe intercambiÁvel para chinelos ou sandÁlias.
ES1061249Y (es) Suela para calzado.
ES1059613Y (es) Suela para calzado.